You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

TEMOVATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Temovate patents expire, and when can generic versions of Temovate launch?

Temovate is a drug marketed by Fougera Pharms and is included in five NDAs.

The generic ingredient in TEMOVATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Temovate

A generic version of TEMOVATE was approved as clobetasol propionate by COSETTE on February 16th, 1994.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TEMOVATE?
  • What are the global sales for TEMOVATE?
  • What is Average Wholesale Price for TEMOVATE?
Summary for TEMOVATE
US Patents:0
Applicants:1
NDAs:5
Raw Ingredient (Bulk) Api Vendors: 80
Clinical Trials: 2
Patent Applications: 4,476
Drug Prices: Drug price information for TEMOVATE
What excipients (inactive ingredients) are in TEMOVATE?TEMOVATE excipients list
DailyMed Link:TEMOVATE at DailyMed
Drug patent expirations by year for TEMOVATE
Drug Prices for TEMOVATE

See drug prices for TEMOVATE

Recent Clinical Trials for TEMOVATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospitals Cleveland Medical CenterN/A
VA Office of Research and DevelopmentN/A
University of UtahPhase 2

See all TEMOVATE clinical trials

US Patents and Regulatory Information for TEMOVATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms TEMOVATE clobetasol propionate GEL;TOPICAL 020337-001 Apr 29, 1994 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms TEMOVATE clobetasol propionate OINTMENT;TOPICAL 019323-001 Dec 27, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms TEMOVATE E clobetasol propionate CREAM;TOPICAL 020340-001 Jun 17, 1994 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TEMOVATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985 ⤷  Sign Up ⤷  Sign Up
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 ⤷  Sign Up ⤷  Sign Up
Fougera Pharms TEMOVATE clobetasol propionate OINTMENT;TOPICAL 019323-001 Dec 27, 1985 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TEMOVATE

See the table below for patents covering TEMOVATE around the world.

Country Patent Number Title Estimated Expiration
Sweden 350035 ⤷  Sign Up
Brazil 6905681 ⤷  Sign Up
Canada 952900 ANTI-INFLAMMATORY STEROIDS OF THE PREGNANE SERIES AND PROCESSES FOR THEIR PREPARATION ⤷  Sign Up
Israel 31447 ANTI-INFLAMMATORY 9,21 DIHALO-17-ALKANOYLOXY-3,20-DIOXO-DELTA4 AND DELTA1,4 STEROIDS OF THE PREGNANE SERIES ⤷  Sign Up
Germany 1902340 21-HALOGEN-17ALPHA-MONOESTER-PREGNA1,4-DIEN-3,20-DION-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ⤷  Sign Up
Switzerland 564035 ⤷  Sign Up
Netherlands 6900795 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.